Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer. (13th October 2022)
- Record Type:
- Journal Article
- Title:
- Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer. (13th October 2022)
- Main Title:
- Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer
- Authors:
- Chen, Wansu
Zhou, Yichen
Xie, Fagen
Butler, Rebecca K.
Jeon, Christie Y.
Luong, Tiffany Q.
Zhou, Botao
Lin, Yu-Chen
Lustigova, Eva
Pisegna, Joseph R.
Kim, Sungjin
Wu, Bechien U. - Abstract:
- Abstract : INTRODUCTION: There is currently no widely accepted approach to screening for pancreatic cancer (PC). We aimed to develop and validate a risk prediction model for pancreatic ductal adenocarcinoma (PDAC), the most common form of PC, across 2 health systems using electronic health records. METHODS: This retrospective cohort study consisted of patients aged 50–84 years having at least 1 clinic-based visit over a 10-year study period at Kaiser Permanente Southern California (model training, internal validation) and the Veterans Affairs (VA, external testing). Random survival forests models were built to identify the most relevant predictors from >500 variables and to predict risk of PDAC within 18 months of cohort entry. RESULTS: The Kaiser Permanente Southern California cohort consisted of 1.8 million patients (mean age 61.6) with 1, 792 PDAC cases. The 18-month incidence rate of PDAC was 0.77 (95% confidence interval 0.73–0.80)/1, 000 person-years. The final main model contained age, abdominal pain, weight change, HbA1c, and alanine transaminase change (c-index: mean = 0.77, SD = 0.02; calibration test: P value 0.4, SD 0.3). The final early detection model comprised the same features as those selected by the main model except for abdominal pain (c-index: 0.77 and SD 0.4; calibration test: P value 0.3 and SD 0.3). The VA testing cohort consisted of 2.7 million patients (mean age 66.1) with an 18-month incidence rate of 1.27 (1.23–1.30)/1, 000 person-years. TheAbstract : INTRODUCTION: There is currently no widely accepted approach to screening for pancreatic cancer (PC). We aimed to develop and validate a risk prediction model for pancreatic ductal adenocarcinoma (PDAC), the most common form of PC, across 2 health systems using electronic health records. METHODS: This retrospective cohort study consisted of patients aged 50–84 years having at least 1 clinic-based visit over a 10-year study period at Kaiser Permanente Southern California (model training, internal validation) and the Veterans Affairs (VA, external testing). Random survival forests models were built to identify the most relevant predictors from >500 variables and to predict risk of PDAC within 18 months of cohort entry. RESULTS: The Kaiser Permanente Southern California cohort consisted of 1.8 million patients (mean age 61.6) with 1, 792 PDAC cases. The 18-month incidence rate of PDAC was 0.77 (95% confidence interval 0.73–0.80)/1, 000 person-years. The final main model contained age, abdominal pain, weight change, HbA1c, and alanine transaminase change (c-index: mean = 0.77, SD = 0.02; calibration test: P value 0.4, SD 0.3). The final early detection model comprised the same features as those selected by the main model except for abdominal pain (c-index: 0.77 and SD 0.4; calibration test: P value 0.3 and SD 0.3). The VA testing cohort consisted of 2.7 million patients (mean age 66.1) with an 18-month incidence rate of 1.27 (1.23–1.30)/1, 000 person-years. The recalibrated main and early detection models based on VA testing data sets achieved a mean c-index of 0.71 (SD 0.002) and 0.68 (SD 0.003), respectively. DISCUSSION: Using widely available parameters in electronic health records, we developed and externally validated parsimonious machine learning-based models for detection of PC. These models may be suitable for real-time clinical application. … (more)
- Is Part Of:
- American journal of gastroenterology. Volume 118:Number 1(2023)
- Journal:
- American journal of gastroenterology
- Issue:
- Volume 118:Number 1(2023)
- Issue Display:
- Volume 118, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 118
- Issue:
- 1
- Issue Sort Value:
- 2023-0118-0001-0000
- Page Start:
- 157
- Page End:
- 167
- Publication Date:
- 2022-10-13
- Subjects:
- Stomach -- Diseases -- Periodicals
Intestines -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Gastrointestinal Diseases -- Periodicals
Electronic journals
Periodicals
616.33 - Journal URLs:
- http://www.mdconsult.com/public/search?search_type=journal&j_sort=pub_date&j_date_range=1995-current&j_issn=0002-9270 ↗
http://www.amjgastro.com/ ↗
http://www.nature.com/ajg/archive/index.html ↗
http://www.sciencedirect.com/science/journal/00029270 ↗
http://www.nature.com/ ↗
http://www3.interscience.wiley.com/journal/117955841/home ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0002-9270;screen=info;ECOIP ↗ - DOI:
- 10.14309/ajg.0000000000002050 ↗
- Languages:
- English
- ISSNs:
- 0002-9270
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0824.650000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25196.xml